↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Thoren M) "

Sökning: WFRF:(Thoren M)

Resultat 31-40 av 415

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
31.	Escudero-Martinez, I, et al. (författare) ASSOCIATION OF CHOLESTEROL LEVELS WITH HEMORRHAGIC TRANSFORMATION AND CEREBRAL EDEMA AFTER REPERFUSION THERAPIES. 2020 Ingår i: INTERNATIONAL JOURNAL OF STROKE. - 1747-4930. ; 15:1_SUPPL, s. 31-31 Konferensbidrag (övrigt vetenskapligt/konstnärligt)
32.	Escudero-Martinez, I, et al. (författare) Cerebral Edema in Patients with severe Hemispheric Syndrome: Incidence, Risk Factors, and Outcomes-Data from SITS-ISTR 2023 Ingår i: Journal of stroke. - : Korean Stroke Society. - 2287-6391 .- 2287-6405. ; 25:1, s. 101- Tidskriftsartikel (refereegranskat)abstract Background and Purpose Cerebral edema (CED) in ischemic stroke can worsen prognosis and about 70% of patients who develop severe CED die if treated conservatively. We aimed to describe incidence, risk factors and outcomes of CED in patients with extensive ischemia.Methods Oservational study based on Safe Implementation of Treatments in Stroke-International Stroke Treatment Registry (2003–2019). Severe hemispheric syndrome (SHS) at baseline and persistent SHS (pSHS) at 24 hours were defined as National Institutes of Health Stroke Score (NIHSS) >15. Outcomes were moderate/severe CED detected by neuroimaging, functional independence (modified Rankin Scale 0–2) and death at 90 days.Results Patients (n=8,560) presented with SHS and developed pSHS at 24 hours; 82.2% received intravenous thrombolysis (IVT), 10.5% IVT+thrombectomy, and 7.3% thrombectomy alone. Median age was 77 and NIHSS 21. Of 7,949 patients with CED data, 3,780 (47.6%) had any CED and 2,297 (28.9%) moderate/severe CED. In the multivariable analysis, age <50 years (relative risk [RR], 1.56), signs of acute infarct (RR, 1.29), hyperdense artery sign (RR, 1.39), blood glucose >128.5 mg/dL (RR, 1.21), and decreased level of consciousness (RR, 1.14) were associated with moderate/severe CED (for all P<0.05). Patients with moderate/severe CED had lower odds to achieve functional Independence (adjusted odds ratio [aOR], 0.35; 95% confidence interval [CI], 0.23 to 0.55) and higher odds of death at 90 days (aOR, 2.54; 95% CI, 2.14 to 3.02).Conclusions In patients with extensive ischemia, the most important predictors for moderate/ severe CED were age <50, high blood glucose, signs of acute infarct, hyperdense artery on baseline scans, and decreased level of consciousness. CED was associated with worse functional outcome and a higher risk of death at 3 months.
33.	Fernholm, R, et al. (författare) Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy 2009 Ingår i: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. - : Elsevier BV. - 1532-2238. ; 19:3, s. 206-211 Tidskriftsartikel (refereegranskat)
34.	Fernholm, R, et al. (författare) Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease 2000 Ingår i: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X. ; 85:11, s. 4104-4112 Tidskriftsartikel (refereegranskat)
35.	Gillberg, P, et al. (författare) Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function. 2001 Ingår i: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. - : Elsevier BV. - 1096-6374. ; 11:5, s. 273-81 Tidskriftsartikel (refereegranskat)abstract The safety and effects of a fixed low dose of growth hormone (GH), 0.17 mg/day was evaluated for 3 months, on glucose metabolism, serum lipids, body composition and cardiac function in 53 GH deficient adults aged 18-78 years. Body composition was determined by dual energy X-ray absorptiometry and total body water was determined by bioelectrical impedance. Echocardiography was used to assess cardiac function and bicycle ergonometry was used to determine exercise capacity. All investigations were performed at baseline and after 3 months. At 3 months, serum levels of insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3 and lipoprotein (a) and lean body mass were increased (P<0.05). Total and low density lipoprotein cholesterol levels and fat mass were reduced (P<0.05). There was an increase in the serum glucose value at 120 min after an oral glucose tolerance test performed at 3 months (P<0.05), no other changes in glucose metabolism or in cardiac function were noted. Side-effects were few and mild. This fixed low-dose regime resulted in improvements in body composition and lipid profile, without causing serious side effects. This is therefore a valid method to institute GH replacement in adults.
36.	HILDING, A, et al. (författare) Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects 1995 Ingår i: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 80:9, s. 2646-2652 Tidskriftsartikel (refereegranskat)
37.	Hilding, A, et al. (författare) Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects 1999 Ingår i: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X. ; 84:6, s. 2013-2019 Tidskriftsartikel (refereegranskat)
38.	Hoybye, C, et al. (författare) Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment 2003 Ingår i: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. - 1096-6374. ; 13:6, s. 322-327 Tidskriftsartikel (refereegranskat)
39.	Jendle, Johan, 1963-, et al. (författare) EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES 2019 Ingår i: Diabetes Technology & Therapeutics. - : Mary Ann Liebert. - 1520-9156 .- 1557-8593. ; 21:Suppl. 1, s. A136-A137 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
40.	KAMEL, A, et al. (författare) Growth hormone (GH) treatment up-regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader-Willi syndrome 1995 Ingår i: Pediatric research. - : Springer Science and Business Media LLC. - 0031-3998 .- 1530-0447. ; 38:3, s. 418-421 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 31-40 av 415

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (385); konferensbidrag (19); forskningsöversikt (5); doktorsavhandling (2); rapport (1); annan publikation (1); visa fler...; bokkapitel (1); recension (1); visa färre...

Typ av innehåll: refereegranskat (390); övrigt vetenskapligt/konstnärligt (23); populärvet., debatt m.m. (2)

Författare/redaktör: Ablikim, M. (275); Wolke, Magnus (274); Schönning, Karin, 19 ... (273); Kupsc, Andrzej (272); Adlarson, Patrik (270); Johansson, Tord (268); visa fler...; Thorén, Viktor (260); Hamberger, B (10); Krieger, K. (10); Falhammar, H (8); Brene, S (6); Nowak, S. (6); Zhang, W. (6); Gorini, G (6); Angioni, C (6); Balden, M (6); Bernert, M (6); Bobkov, V (6); Bolzonella, T (6); Brezinsek, S (6); Coelho, R (6); Colas, L (6); Coster, D (6); Cseh, G (6); Dux, R (6); Giovannozzi, E (6); Groth, M (6); Hobirk, J (6); Kappatou, A (6); Kurki-Suonio, Taina, ... (6); Lehnen, M (6); Mantica, P (6); Nabais, F (6); Neu, R (6); Nocente, M (6); Putterich, T (6); Refy, D (6); Reiser, D (6); Saarelma, S (6); Salewski, M (6); Salmi, A (6); Sauter, O (6); Sieglin, B (6); Sozzi, C (6); Tala, T (6); Tardocchi, M (6); Valisa, M (6); Wischmeier, M (6); Zagorski, R (6); Zoletnik, S (6); visa färre...

Lärosäte: Uppsala universitet (287); Karolinska Institutet (88); Kungliga Tekniska Högskolan (19); Göteborgs universitet (17); Lunds universitet (11); Chalmers tekniska högskola (8); visa fler...; Linköpings universitet (3); Högskolan i Borås (3); Umeå universitet (2); Örebro universitet (2); Malmö universitet (1); Högskolan i Skövde (1); Linnéuniversitetet (1); RISE (1); Försvarshögskolan (1); Sveriges Lantbruksuniversitet (1); visa färre...

Språk: Engelska (411); Svenska (2); Latin (2)

Forskningsämne (UKÄ/SCB): Naturvetenskap (297); Medicin och hälsovetenskap (28); Teknik (9); Lantbruksvetenskap (2); Samhällsvetenskap (1); Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy